BIOBASE

Jinan Has Become a Household Name for Holding the World Advanced Manufacturing Conference Twice

Retrieved on: 
Tuesday, November 1, 2022
Other Manufacturing, Technology, Engineering, Manufacturing, Machinery, Machine Tools, Metalworking & Metallurgy, Hardware, Electronic Design Automation, Artificial Intelligence, Hydrogen, Information technology, Science, Efficiency, Big data, CPC, Work, Diplomatic mission, Intelligence, Exhibition, Embassy of Japan, Washington, D.C., CCID Consulting, Chinese Academy of Engineering, Energy Research Institute of the Russian Academy of Sciences, Achievement, Sun Bin, Tiangong space station, Digital supply chain, Guinean League for Ecological Protection, Chinese Academy of Sciences, Decision-making, Technology, The, Multimedia, National, Committee, Empowerment, Orangi Pilot Project, Academy of sciences, Policy, Conference, Household name, 2022 Winter Olympics, RMB, Central committee, BIOBASE, Start, Benchmarking, High End Systems, Video game, Television, Renewable energy, Mobile phone, Industry, Engineering, Synthesis, Inspur, Joyoung

The 2022 World Advanced Manufacturing Conference opened in Jinan, the capital of East China's Shandong province on Aug 31.

Key Points: 
  • The 2022 World Advanced Manufacturing Conference opened in Jinan, the capital of East China's Shandong province on Aug 31.
  • Manufacturing in Jinan demonstrates Jinan's powerful strength in advanced manufacturing and the digital economy.
  • Yu Haitian, Vice Party Secretary of CPC Jinan Municipal Committee and Mayor of Jinan, released the 2022 World Advanced Manufacturing Conference Jinan Declaration.
  • According to Ji Peide, director of Jinan Municipal Bureau of Industry and Information Technology, Jinan will hold the World Advanced Manufacturing Conference in the future.

Cryostat Market worth $2.8 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, September 26, 2022
Amos, Knowledge, GM, GEM, Industry, USD, Laboratory, PT, Microtome, Ecosystem, National Aeronautic Association, Research, Temperature, COVID-19, AG, Growth, Cryostat, Hardware, Scilab, Science, Medicine, CAGR, Nitrogen, JT, Leica Biosystems, Tissue, Helium, Metallurgy, BIOBASE, NASA, Engineering, MRI, Intelligence, SME, Pathology, Biotechnology, WISE, Heliox (cryogenic equipment), Medical imaging, Marketing, Thermistor, Geography, Infrared, Application

CHICAGO, Sept. 26, 2022 /PRNewswire/ -- Cryostat market is projected to reach USD 2.8 billion by 2027 from USD 2.2 billion in 2022; it is expected to grow at a CAGR of 4.9% from 2022 to 2027, according to a new report by MarketsandMarkets.

Key Points: 
  • CHICAGO, Sept. 26, 2022 /PRNewswire/ -- Cryostat market is projected to reach USD 2.8 billion by 2027 from USD 2.2 billion in 2022; it is expected to grow at a CAGR of 4.9% from 2022 to 2027, according to a new report by MarketsandMarkets.
  • However, factors such as leakage of cryogen gases, which may have some environmental hazards, can affect the market growth adversely.
  • The market segmentation represents various aspects of the market on the basis of type, system component, cryogen, industry, and geography.
  • Temperature control of the sample within the cryostat is typically performed by controlling the cryogen flow rate into the cryostat.

Cryostat Market worth $2.8 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, September 26, 2022
Amos, Knowledge, GM, GEM, Industry, USD, Laboratory, PT, Microtome, Ecosystem, National Aeronautic Association, Research, Temperature, COVID-19, AG, Growth, Cryostat, Hardware, Scilab, Science, Medicine, CAGR, Nitrogen, JT, Leica Biosystems, Tissue, Helium, Metallurgy, BIOBASE, NASA, Engineering, MRI, Intelligence, SME, Pathology, Biotechnology, WISE, Heliox (cryogenic equipment), Medical imaging, Marketing, Thermistor, Geography, Infrared, Application

CHICAGO, Sept. 26, 2022 /PRNewswire/ -- Cryostat market is projected to reach USD 2.8 billion by 2027 from USD 2.2 billion in 2022; it is expected to grow at a CAGR of 4.9% from 2022 to 2027, according to a new report by MarketsandMarkets.

Key Points: 
  • CHICAGO, Sept. 26, 2022 /PRNewswire/ -- Cryostat market is projected to reach USD 2.8 billion by 2027 from USD 2.2 billion in 2022; it is expected to grow at a CAGR of 4.9% from 2022 to 2027, according to a new report by MarketsandMarkets.
  • However, factors such as leakage of cryogen gases, which may have some environmental hazards, can affect the market growth adversely.
  • The market segmentation represents various aspects of the market on the basis of type, system component, cryogen, industry, and geography.
  • Temperature control of the sample within the cryostat is typically performed by controlling the cryogen flow rate into the cryostat.

Global Pharmaceutical Packaging Market is Expected to Grow at a CAGR of over 9.5% During 2021-2030 - ResearchAndMarkets.com

Retrieved on: 
Monday, February 21, 2022
Packaging, Pharmaceutical, Health, Manufacturing, Asia-Pacific, Conditional sentence, Growth, Prevalence, COVID-19, Heat, Schott AG, Plastic, Tablet, Blister, USD, BIOBASE, Cancer, Polymer, Traction, Technology, BFS, CAGR, Capsule, Fine chemical, Glass

The global pharmaceutical packaging market size is expected to reach USD 265.5 billion by 2030.

Key Points: 
  • The global pharmaceutical packaging market size is expected to reach USD 265.5 billion by 2030.
  • The increasing prevalence of chronic diseases, coupled with the growth of the pharmaceutical industry, is anticipated to augment the consumption of pharmaceutical packaging products.
  • Therefore, the growing demand for anti-counterfeiting packaging, along with the advent of technology, is likely to support the growth of tamper-evident pharmaceutical packaging.
  • This factor is boosting the demand for contract packaging services
    Asia Pacific is projected to be the fastest-growing regional market from 2021 to 2030.

Alzheon Appoints Adem Albayrak as Head of Operations and Earvin Liang, PhD, as Vice President of Clinical Development

Retrieved on: 
Monday, September 13, 2021
Research, Mental Health, Clinical Trials, Other Health, Biotechnology, General Health, Pharmaceutical, Health, Science, Other Science, Genotype, Pathology, Qiagen, Whole genome sequencing, Patient, National Institute on Aging, Head, Research, Drug, Ageing, Biology, Biomarker, Neurotoxicity, Data visualization, University of Massachusetts Medical School, MD, Amyloid, Organization, Computer science, Cognition, APOE4, Acquisition, National Institute, Cancer, Alzheimer's disease, Leadership, Fast Track, Precision medicine, AD, Food, Therapy, Dementia, Semper Fidelis (march), Down syndrome, University, Technology, Safety, Senior, Brain, Dana–Farber Cancer Institute, Medical school, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Harvard Business School, Doctor of Philosophy, Neurodegeneration, Genomics, Risk, Clinical trial, Industry, Taipei Medical University, Transition, BIOBASE, Pharmaceutical industry, Medical imaging, ALZ-801, Alzheon, ALZ-801, ALZHEON

Mr. Albayrak brings more than a decade of precision medicine experience in both biopharma and academic medical centers to drive execution of Alzheons business and clinical programs.

Key Points: 
  • Mr. Albayrak brings more than a decade of precision medicine experience in both biopharma and academic medical centers to drive execution of Alzheons business and clinical programs.
  • Most recently, Mr. Albayrak served as the Senior Vice President for Technology in Health Catalysts emerging Life Sciences Business, where he led development of new products and analytical capabilities.
  • Subsequently, he led product development of pharmacogenomics products at BIOBASE, before its acquisition by Qiagen.
  • While at Dana-Farber Cancer Institute, Mr. Albayrak oversaw its precision medicine activities, enabling research, clinical interpretation, and clinical trial matching of the hospitals genomic sequencing program, Profile.

Global Pharmaceutical Packaging Market Size, Share & Trends Analysis Report 2021-2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 1, 2021
Health, Pharmaceutical, Capsule, CAGR, Growth, Cancer, Traction, Glass, Blister, BFS, Conditional sentence, Scope, Plastic, Prevalence, Degenerative disease, BIOBASE, Tablet, 2020–2021 China–India skirmishes, COVID-19, USD, Technology, Polymer, Vaccine, Fine chemical

The "Pharmaceutical Packaging Market Size, Share & Trends Analysis Report by Material (Glass, Plastics & Polymers), by Product (Primary, Secondary), by End Use, by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pharmaceutical Packaging Market Size, Share & Trends Analysis Report by Material (Glass, Plastics & Polymers), by Product (Primary, Secondary), by End Use, by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global pharmaceutical packaging market size is expected to reach USD 219.2 billion by 2028, expanding at a CAGR of 9.4%
    The increasing prevalence of chronic diseases coupled with the growth of the pharmaceutical industry is anticipated to augment the consumption of pharmaceutical packaging products.
  • Therefore, the growing demand for anti-counterfeiting packaging along with the advent of technology is likely to support the growth of tamper-evident pharmaceutical packaging.
  • This growth is due to the rapidly expanding pharmaceutical market, particularly in China & India, and rising cases of various diseases, such as cancer and heart problems
    Chapter 3 Pharmaceutical Packaging Market Variables, Trends, and Scope